Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells

AIMS: Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) have become a promising tool in cardiovascular safety pharmacology. Immaturity of iPS-CMs remains an ongoing concern. We compared electrophysiological and contractile features of cardiac bodies (hiPS-CBs) derived from human-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Trieschmann, Jan, Haustein, Moritz, Köster, Annette, Hescheler, Jürgen, Brockmeier, Konrad, Bennink, Gerardus, Hannes, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431377/
https://www.ncbi.nlm.nih.gov/pubmed/30956672
http://dx.doi.org/10.1155/2019/6096294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431377/
https://www.ncbi.nlm.nih.gov/pubmed/30956672
http://dx.doi.org/10.1155/2019/6096294

Ejemplares similares